CytoMed Therapeutics CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers. | ![]() Nexomics Biosciences Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community. | Exicure Exicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets. | Spotlight Therapeutics Spotlight Therapeutics is a biotechnology company that develops therapeutics by enabling direct in vivo gene editing. | ||
Founding Date | Founding Date 2018 | Founding Date 2007 | Founding Date 2000 | Founding Date 2011 | Founding Date 2017 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Singapore, SG HQ Masai, MY | Locations Rocky Hill, US HQ Mansfield, US | Locations HQ | Locations Skokie, US HQ Chicago, US | Locations Hayward, US HQ |
Employees | Employees 24 | Employees 1220% increase | Employees 563 | Employees 29 | Employees 1914% decrease |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income (₩33.6b) (FY, 2023) | Net income ($4.9m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 94m | Total funding raised $ 14.2m |

Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community.
View companyExicure is a biotechnology company developing immunomodulatory and gene regulating drugs against validated targets.
View companySpotlight Therapeutics is a biotechnology company that develops therapeutics by enabling direct in vivo gene editing.
View company